These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 18162858
1. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004. Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M. Med Care; 2008 Jan; 46(1):70-7. PubMed ID: 18162858 [Abstract] [Full Text] [Related]
2. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care. Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C. J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867 [Abstract] [Full Text] [Related]
4. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. Austin PC, Tu JV, Ko DT, Alter DA. CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455 [Abstract] [Full Text] [Related]
5. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis. van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A. Clin Ther; 2005 Nov 21; 27(11):1806-14. PubMed ID: 16368451 [Abstract] [Full Text] [Related]
7. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap? Hudson M, Richard H, Pilote L. Pharmacoepidemiol Drug Saf; 2007 Jul 21; 16(7):773-85. PubMed ID: 17486661 [Abstract] [Full Text] [Related]
9. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP. Eur J Vasc Endovasc Surg; 2008 Jan 21; 35(1):51-8. PubMed ID: 17923426 [Abstract] [Full Text] [Related]
10. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362 [Abstract] [Full Text] [Related]
15. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. Vermeer NS, Bajorek BV. J Clin Pharm Ther; 2008 Dec 01; 33(6):591-601. PubMed ID: 19138236 [Abstract] [Full Text] [Related]
16. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA. Arch Intern Med; 2008 Mar 10; 168(5):485-91; discussion 492. PubMed ID: 18332293 [Abstract] [Full Text] [Related]
18. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction. Vitagliano G, Curtis JP, Concato J, Feinstein AR, Radford MJ, Krumholz HM. J Am Geriatr Soc; 2004 Apr 10; 52(4):495-501. PubMed ID: 15066062 [Abstract] [Full Text] [Related]
19. Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction? Tu K, Gunraj N, Mamdani M. Am J Cardiol; 2006 Jul 01; 98(1):6-9. PubMed ID: 16784910 [Abstract] [Full Text] [Related]